nodes	percent_of_prediction	percent_of_DWPC	metapath
Nalbuphine—Anxiety—Erlotinib—pancreatic cancer	0.0024	0.00472	CcSEcCtD
Nalbuphine—Dysgeusia—Sunitinib—pancreatic cancer	0.0024	0.00472	CcSEcCtD
Nalbuphine—Dry mouth—Tamoxifen—pancreatic cancer	0.00238	0.00468	CcSEcCtD
Nalbuphine—Bradycardia—Irinotecan—pancreatic cancer	0.00236	0.00464	CcSEcCtD
Nalbuphine—Muscle spasms—Sunitinib—pancreatic cancer	0.00235	0.00463	CcSEcCtD
Nalbuphine—Oedema—Tamoxifen—pancreatic cancer	0.00233	0.00459	CcSEcCtD
Nalbuphine—Oedema—Erlotinib—pancreatic cancer	0.00231	0.00454	CcSEcCtD
Nalbuphine—Shock—Erlotinib—pancreatic cancer	0.00227	0.00447	CcSEcCtD
Nalbuphine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00226	0.00444	CcSEcCtD
Nalbuphine—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.00221	0.00434	CcSEcCtD
Nalbuphine—Flushing—Irinotecan—pancreatic cancer	0.00215	0.00423	CcSEcCtD
Nalbuphine—Injection site reaction—Epirubicin—pancreatic cancer	0.00214	0.00421	CcSEcCtD
Nalbuphine—Convulsion—Sunitinib—pancreatic cancer	0.00212	0.00417	CcSEcCtD
Nalbuphine—Hypertension—Sunitinib—pancreatic cancer	0.00211	0.00416	CcSEcCtD
Nalbuphine—Paraesthesia—Tamoxifen—pancreatic cancer	0.00209	0.00412	CcSEcCtD
Nalbuphine—Cramp muscle—Docetaxel—pancreatic cancer	0.00208	0.0041	CcSEcCtD
Nalbuphine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00208	0.00409	CcSEcCtD
Nalbuphine—Dyspnoea—Erlotinib—pancreatic cancer	0.00206	0.00405	CcSEcCtD
Nalbuphine—Dyspepsia—Tamoxifen—pancreatic cancer	0.00205	0.00404	CcSEcCtD
Nalbuphine—Dry mouth—Sunitinib—pancreatic cancer	0.00204	0.00401	CcSEcCtD
Nalbuphine—Dyspepsia—Erlotinib—pancreatic cancer	0.00203	0.004	CcSEcCtD
Nalbuphine—Oedema—Sunitinib—pancreatic cancer	0.002	0.00393	CcSEcCtD
Nalbuphine—Injection site reaction—Doxorubicin—pancreatic cancer	0.00198	0.00389	CcSEcCtD
Nalbuphine—Bronchospasm—Docetaxel—pancreatic cancer	0.00197	0.00387	CcSEcCtD
Nalbuphine—Shock—Sunitinib—pancreatic cancer	0.00197	0.00387	CcSEcCtD
Nalbuphine—Erythema—Gemcitabine—pancreatic cancer	0.00196	0.00387	CcSEcCtD
Nalbuphine—Muscle spasms—Irinotecan—pancreatic cancer	0.00194	0.00382	CcSEcCtD
Nalbuphine—Erythema—Fluorouracil—pancreatic cancer	0.00193	0.0038	CcSEcCtD
Nalbuphine—Pulmonary oedema—Epirubicin—pancreatic cancer	0.00191	0.00377	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00191	0.00375	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00189	0.00371	CcSEcCtD
Nalbuphine—Urticaria—Tamoxifen—pancreatic cancer	0.00185	0.00365	CcSEcCtD
Nalbuphine—Abdominal pain—Tamoxifen—pancreatic cancer	0.00184	0.00363	CcSEcCtD
Nalbuphine—Abdominal pain—Erlotinib—pancreatic cancer	0.00182	0.00359	CcSEcCtD
Nalbuphine—Body temperature increased—Erlotinib—pancreatic cancer	0.00182	0.00359	CcSEcCtD
Nalbuphine—Vision blurred—Fluorouracil—pancreatic cancer	0.00182	0.00358	CcSEcCtD
Nalbuphine—Vertigo—Irinotecan—pancreatic cancer	0.00181	0.00357	CcSEcCtD
Nalbuphine—Syncope—Irinotecan—pancreatic cancer	0.00181	0.00356	CcSEcCtD
Nalbuphine—Paraesthesia—Sunitinib—pancreatic cancer	0.00179	0.00353	CcSEcCtD
Nalbuphine—Dyspnoea—Sunitinib—pancreatic cancer	0.00178	0.00351	CcSEcCtD
Nalbuphine—Loss of consciousness—Irinotecan—pancreatic cancer	0.00177	0.00349	CcSEcCtD
Nalbuphine—Pulmonary oedema—Doxorubicin—pancreatic cancer	0.00177	0.00349	CcSEcCtD
Nalbuphine—Dyspepsia—Sunitinib—pancreatic cancer	0.00176	0.00346	CcSEcCtD
Nalbuphine—Hypertension—Irinotecan—pancreatic cancer	0.00174	0.00343	CcSEcCtD
Nalbuphine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00172	0.00338	CcSEcCtD
Nalbuphine—Hypertension—Gemcitabine—pancreatic cancer	0.0017	0.00334	CcSEcCtD
Nalbuphine—Asthenia—Tamoxifen—pancreatic cancer	0.00167	0.00329	CcSEcCtD
Nalbuphine—Convulsion—Fluorouracil—pancreatic cancer	0.00167	0.00329	CcSEcCtD
Nalbuphine—Confusional state—Irinotecan—pancreatic cancer	0.00166	0.00327	CcSEcCtD
Nalbuphine—Asthenia—Erlotinib—pancreatic cancer	0.00166	0.00326	CcSEcCtD
Nalbuphine—Pruritus—Tamoxifen—pancreatic cancer	0.00165	0.00325	CcSEcCtD
Nalbuphine—Oedema—Irinotecan—pancreatic cancer	0.00165	0.00324	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00163	0.00322	CcSEcCtD
Nalbuphine—Pruritus—Erlotinib—pancreatic cancer	0.00163	0.00321	CcSEcCtD
Nalbuphine—Shock—Irinotecan—pancreatic cancer	0.00162	0.00319	CcSEcCtD
Nalbuphine—Oedema—Gemcitabine—pancreatic cancer	0.0016	0.00316	CcSEcCtD
Nalbuphine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.00159	0.00314	CcSEcCtD
Nalbuphine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.00159	0.00313	CcSEcCtD
Nalbuphine—Confusional state—Fluorouracil—pancreatic cancer	0.00159	0.00313	CcSEcCtD
Nalbuphine—Abdominal pain—Sunitinib—pancreatic cancer	0.00158	0.00311	CcSEcCtD
Nalbuphine—Body temperature increased—Sunitinib—pancreatic cancer	0.00158	0.00311	CcSEcCtD
Nalbuphine—Oedema—Fluorouracil—pancreatic cancer	0.00158	0.0031	CcSEcCtD
Nalbuphine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.00155	0.00305	CcSEcCtD
Nalbuphine—Dizziness—Tamoxifen—pancreatic cancer	0.00154	0.00304	CcSEcCtD
Nalbuphine—Tachycardia—Fluorouracil—pancreatic cancer	0.00154	0.00303	CcSEcCtD
Nalbuphine—Hypotension—Irinotecan—pancreatic cancer	0.00154	0.00303	CcSEcCtD
Nalbuphine—Dizziness—Erlotinib—pancreatic cancer	0.00153	0.003	CcSEcCtD
Nalbuphine—Hypotension—Gemcitabine—pancreatic cancer	0.0015	0.00295	CcSEcCtD
Nalbuphine—Flushing—Docetaxel—pancreatic cancer	0.00149	0.00293	CcSEcCtD
Nalbuphine—Cardiac arrest—Epirubicin—pancreatic cancer	0.00148	0.00292	CcSEcCtD
Nalbuphine—Vomiting—Tamoxifen—pancreatic cancer	0.00148	0.00292	CcSEcCtD
Nalbuphine—Paraesthesia—Irinotecan—pancreatic cancer	0.00148	0.00291	CcSEcCtD
Nalbuphine—Hypotension—Fluorouracil—pancreatic cancer	0.00147	0.0029	CcSEcCtD
Nalbuphine—Hypersensitivity—Sunitinib—pancreatic cancer	0.00147	0.0029	CcSEcCtD
Nalbuphine—Rash—Tamoxifen—pancreatic cancer	0.00147	0.00289	CcSEcCtD
Nalbuphine—Dermatitis—Tamoxifen—pancreatic cancer	0.00147	0.00289	CcSEcCtD
Nalbuphine—Vomiting—Erlotinib—pancreatic cancer	0.00147	0.00289	CcSEcCtD
Nalbuphine—Dyspnoea—Irinotecan—pancreatic cancer	0.00147	0.00289	CcSEcCtD
Nalbuphine—Somnolence—Irinotecan—pancreatic cancer	0.00146	0.00288	CcSEcCtD
Nalbuphine—Headache—Tamoxifen—pancreatic cancer	0.00146	0.00288	CcSEcCtD
Nalbuphine—Rash—Erlotinib—pancreatic cancer	0.00146	0.00286	CcSEcCtD
Nalbuphine—Dermatitis—Erlotinib—pancreatic cancer	0.00145	0.00286	CcSEcCtD
Nalbuphine—Dyspepsia—Irinotecan—pancreatic cancer	0.00145	0.00285	CcSEcCtD
Nalbuphine—Headache—Erlotinib—pancreatic cancer	0.00145	0.00285	CcSEcCtD
Nalbuphine—Paraesthesia—Gemcitabine—pancreatic cancer	0.00144	0.00283	CcSEcCtD
Nalbuphine—Asthenia—Sunitinib—pancreatic cancer	0.00143	0.00282	CcSEcCtD
Nalbuphine—Dyspnoea—Gemcitabine—pancreatic cancer	0.00143	0.00281	CcSEcCtD
Nalbuphine—Somnolence—Gemcitabine—pancreatic cancer	0.00143	0.00281	CcSEcCtD
Nalbuphine—Paraesthesia—Fluorouracil—pancreatic cancer	0.00142	0.00279	CcSEcCtD
Nalbuphine—Pruritus—Sunitinib—pancreatic cancer	0.00141	0.00278	CcSEcCtD
Nalbuphine—Dyspnoea—Fluorouracil—pancreatic cancer	0.00141	0.00277	CcSEcCtD
Nalbuphine—Somnolence—Fluorouracil—pancreatic cancer	0.0014	0.00276	CcSEcCtD
Nalbuphine—Erythema—Docetaxel—pancreatic cancer	0.00139	0.00274	CcSEcCtD
Nalbuphine—Dyspepsia—Fluorouracil—pancreatic cancer	0.00139	0.00273	CcSEcCtD
Nalbuphine—Nausea—Tamoxifen—pancreatic cancer	0.00139	0.00273	CcSEcCtD
Nalbuphine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.00137	0.0027	CcSEcCtD
Nalbuphine—Nausea—Erlotinib—pancreatic cancer	0.00137	0.0027	CcSEcCtD
Nalbuphine—Dysgeusia—Docetaxel—pancreatic cancer	0.00137	0.00269	CcSEcCtD
Nalbuphine—Feeling abnormal—Irinotecan—pancreatic cancer	0.00136	0.00267	CcSEcCtD
Nalbuphine—Asthma—Epirubicin—pancreatic cancer	0.00135	0.00266	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.00135	0.00265	CcSEcCtD
Nalbuphine—Muscle spasms—Docetaxel—pancreatic cancer	0.00134	0.00264	CcSEcCtD
Nalbuphine—Dizziness—Sunitinib—pancreatic cancer	0.00132	0.0026	CcSEcCtD
Nalbuphine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00132	0.0026	CcSEcCtD
Nalbuphine—Body temperature increased—Irinotecan—pancreatic cancer	0.0013	0.00256	CcSEcCtD
Nalbuphine—Abdominal pain—Irinotecan—pancreatic cancer	0.0013	0.00256	CcSEcCtD
Nalbuphine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.0013	0.00256	CcSEcCtD
Nalbuphine—Vomiting—Sunitinib—pancreatic cancer	0.00127	0.0025	CcSEcCtD
Nalbuphine—Body temperature increased—Gemcitabine—pancreatic cancer	0.00127	0.00249	CcSEcCtD
Nalbuphine—Rash—Sunitinib—pancreatic cancer	0.00126	0.00248	CcSEcCtD
Nalbuphine—Dermatitis—Sunitinib—pancreatic cancer	0.00126	0.00248	CcSEcCtD
Nalbuphine—Urticaria—Fluorouracil—pancreatic cancer	0.00125	0.00246	CcSEcCtD
Nalbuphine—Headache—Sunitinib—pancreatic cancer	0.00125	0.00246	CcSEcCtD
Nalbuphine—Syncope—Docetaxel—pancreatic cancer	0.00125	0.00246	CcSEcCtD
Nalbuphine—Asthma—Doxorubicin—pancreatic cancer	0.00125	0.00246	CcSEcCtD
Nalbuphine—Pollakiuria—Epirubicin—pancreatic cancer	0.00125	0.00245	CcSEcCtD
Nalbuphine—Body temperature increased—Fluorouracil—pancreatic cancer	0.00125	0.00245	CcSEcCtD
Nalbuphine—Loss of consciousness—Docetaxel—pancreatic cancer	0.00123	0.00241	CcSEcCtD
Nalbuphine—Hypersensitivity—Irinotecan—pancreatic cancer	0.00121	0.00239	CcSEcCtD
Nalbuphine—Convulsion—Docetaxel—pancreatic cancer	0.00121	0.00238	CcSEcCtD
Nalbuphine—Hypertension—Docetaxel—pancreatic cancer	0.0012	0.00237	CcSEcCtD
Nalbuphine—Nausea—Sunitinib—pancreatic cancer	0.00119	0.00234	CcSEcCtD
Nalbuphine—Asthenia—Irinotecan—pancreatic cancer	0.00118	0.00232	CcSEcCtD
Nalbuphine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00116	0.00229	CcSEcCtD
Nalbuphine—Dry mouth—Docetaxel—pancreatic cancer	0.00116	0.00228	CcSEcCtD
Nalbuphine—Pollakiuria—Doxorubicin—pancreatic cancer	0.00115	0.00227	CcSEcCtD
Nalbuphine—Asthenia—Gemcitabine—pancreatic cancer	0.00115	0.00226	CcSEcCtD
Nalbuphine—Confusional state—Docetaxel—pancreatic cancer	0.00115	0.00226	CcSEcCtD
Nalbuphine—Oedema—Docetaxel—pancreatic cancer	0.00114	0.00224	CcSEcCtD
Nalbuphine—Pruritus—Gemcitabine—pancreatic cancer	0.00113	0.00223	CcSEcCtD
Nalbuphine—Shock—Docetaxel—pancreatic cancer	0.00112	0.0022	CcSEcCtD
Nalbuphine—Pruritus—Fluorouracil—pancreatic cancer	0.00112	0.00219	CcSEcCtD
Nalbuphine—Tachycardia—Docetaxel—pancreatic cancer	0.00111	0.00219	CcSEcCtD
Nalbuphine—Bradycardia—Epirubicin—pancreatic cancer	0.0011	0.00216	CcSEcCtD
Nalbuphine—Dizziness—Irinotecan—pancreatic cancer	0.00109	0.00214	CcSEcCtD
Nalbuphine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.00107	0.00212	CcSEcCtD
Nalbuphine—Hypotension—Docetaxel—pancreatic cancer	0.00106	0.00209	CcSEcCtD
Nalbuphine—Vomiting—Irinotecan—pancreatic cancer	0.00105	0.00206	CcSEcCtD
Nalbuphine—Dizziness—Fluorouracil—pancreatic cancer	0.00104	0.00205	CcSEcCtD
Nalbuphine—Rash—Irinotecan—pancreatic cancer	0.00104	0.00204	CcSEcCtD
Nalbuphine—Dermatitis—Irinotecan—pancreatic cancer	0.00104	0.00204	CcSEcCtD
Nalbuphine—Headache—Irinotecan—pancreatic cancer	0.00103	0.00203	CcSEcCtD
Nalbuphine—Paraesthesia—Docetaxel—pancreatic cancer	0.00102	0.00201	CcSEcCtD
Nalbuphine—Vomiting—Gemcitabine—pancreatic cancer	0.00102	0.00201	CcSEcCtD
Nalbuphine—Bradycardia—Doxorubicin—pancreatic cancer	0.00102	0.002	CcSEcCtD
Nalbuphine—Dyspnoea—Docetaxel—pancreatic cancer	0.00101	0.002	CcSEcCtD
Nalbuphine—Somnolence—Docetaxel—pancreatic cancer	0.00101	0.00199	CcSEcCtD
Nalbuphine—Rash—Gemcitabine—pancreatic cancer	0.00101	0.00199	CcSEcCtD
Nalbuphine—Dermatitis—Gemcitabine—pancreatic cancer	0.00101	0.00199	CcSEcCtD
Nalbuphine—Headache—Gemcitabine—pancreatic cancer	0.001	0.00198	CcSEcCtD
Nalbuphine—Flushing—Epirubicin—pancreatic cancer	0.001	0.00197	CcSEcCtD
Nalbuphine—Vomiting—Fluorouracil—pancreatic cancer	0.001	0.00197	CcSEcCtD
Nalbuphine—Dyspepsia—Docetaxel—pancreatic cancer	0.001	0.00197	CcSEcCtD
Nalbuphine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000994	0.00196	CcSEcCtD
Nalbuphine—Rash—Fluorouracil—pancreatic cancer	0.000994	0.00196	CcSEcCtD
Nalbuphine—Dermatitis—Fluorouracil—pancreatic cancer	0.000993	0.00195	CcSEcCtD
Nalbuphine—Headache—Fluorouracil—pancreatic cancer	0.000987	0.00194	CcSEcCtD
Nalbuphine—Nausea—Irinotecan—pancreatic cancer	0.000978	0.00192	CcSEcCtD
Nalbuphine—Nausea—Gemcitabine—pancreatic cancer	0.000952	0.00187	CcSEcCtD
Nalbuphine—Erythema—Epirubicin—pancreatic cancer	0.00094	0.00185	CcSEcCtD
Nalbuphine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000937	0.00185	CcSEcCtD
Nalbuphine—Nausea—Fluorouracil—pancreatic cancer	0.000936	0.00184	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00093	0.00183	CcSEcCtD
Nalbuphine—Flushing—Doxorubicin—pancreatic cancer	0.000927	0.00183	CcSEcCtD
Nalbuphine—Tension—Epirubicin—pancreatic cancer	0.000923	0.00182	CcSEcCtD
Nalbuphine—Dysgeusia—Epirubicin—pancreatic cancer	0.000921	0.00181	CcSEcCtD
Nalbuphine—Nervousness—Epirubicin—pancreatic cancer	0.000913	0.0018	CcSEcCtD
Nalbuphine—Muscle spasms—Epirubicin—pancreatic cancer	0.000904	0.00178	CcSEcCtD
Nalbuphine—Body temperature increased—Docetaxel—pancreatic cancer	0.000899	0.00177	CcSEcCtD
Nalbuphine—Abdominal pain—Docetaxel—pancreatic cancer	0.000899	0.00177	CcSEcCtD
Nalbuphine—Vision blurred—Epirubicin—pancreatic cancer	0.000886	0.00174	CcSEcCtD
Nalbuphine—Erythema—Doxorubicin—pancreatic cancer	0.00087	0.00171	CcSEcCtD
Nalbuphine—Agitation—Epirubicin—pancreatic cancer	0.000864	0.0017	CcSEcCtD
Nalbuphine—Tension—Doxorubicin—pancreatic cancer	0.000854	0.00168	CcSEcCtD
Nalbuphine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000852	0.00168	CcSEcCtD
Nalbuphine—Nervousness—Doxorubicin—pancreatic cancer	0.000845	0.00166	CcSEcCtD
Nalbuphine—Vertigo—Epirubicin—pancreatic cancer	0.000845	0.00166	CcSEcCtD
Nalbuphine—Syncope—Epirubicin—pancreatic cancer	0.000843	0.00166	CcSEcCtD
Nalbuphine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000838	0.00165	CcSEcCtD
Nalbuphine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000836	0.00165	CcSEcCtD
Nalbuphine—Loss of consciousness—Epirubicin—pancreatic cancer	0.000826	0.00163	CcSEcCtD
Nalbuphine—Vision blurred—Doxorubicin—pancreatic cancer	0.00082	0.00161	CcSEcCtD
Nalbuphine—Asthenia—Docetaxel—pancreatic cancer	0.000816	0.00161	CcSEcCtD
Nalbuphine—Convulsion—Epirubicin—pancreatic cancer	0.000815	0.0016	CcSEcCtD
Nalbuphine—Hypertension—Epirubicin—pancreatic cancer	0.000812	0.0016	CcSEcCtD
Nalbuphine—Pruritus—Docetaxel—pancreatic cancer	0.000805	0.00158	CcSEcCtD
Nalbuphine—Agitation—Doxorubicin—pancreatic cancer	0.000799	0.00157	CcSEcCtD
Nalbuphine—Anxiety—Epirubicin—pancreatic cancer	0.000798	0.00157	CcSEcCtD
Nalbuphine—Dry mouth—Epirubicin—pancreatic cancer	0.000783	0.00154	CcSEcCtD
Nalbuphine—Vertigo—Doxorubicin—pancreatic cancer	0.000782	0.00154	CcSEcCtD
Nalbuphine—Syncope—Doxorubicin—pancreatic cancer	0.00078	0.00154	CcSEcCtD
Nalbuphine—Confusional state—Epirubicin—pancreatic cancer	0.000774	0.00152	CcSEcCtD
Nalbuphine—Oedema—Epirubicin—pancreatic cancer	0.000767	0.00151	CcSEcCtD
Nalbuphine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000765	0.0015	CcSEcCtD
Nalbuphine—Shock—Epirubicin—pancreatic cancer	0.000755	0.00149	CcSEcCtD
Nalbuphine—Convulsion—Doxorubicin—pancreatic cancer	0.000754	0.00148	CcSEcCtD
Nalbuphine—Dizziness—Docetaxel—pancreatic cancer	0.000752	0.00148	CcSEcCtD
Nalbuphine—Hypertension—Doxorubicin—pancreatic cancer	0.000751	0.00148	CcSEcCtD
Nalbuphine—Tachycardia—Epirubicin—pancreatic cancer	0.000749	0.00147	CcSEcCtD
Nalbuphine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000742	0.00146	CcSEcCtD
Nalbuphine—Anxiety—Doxorubicin—pancreatic cancer	0.000738	0.00145	CcSEcCtD
Nalbuphine—Dry mouth—Doxorubicin—pancreatic cancer	0.000724	0.00143	CcSEcCtD
Nalbuphine—Vomiting—Docetaxel—pancreatic cancer	0.000723	0.00142	CcSEcCtD
Nalbuphine—Rash—Docetaxel—pancreatic cancer	0.000717	0.00141	CcSEcCtD
Nalbuphine—Hypotension—Epirubicin—pancreatic cancer	0.000717	0.00141	CcSEcCtD
Nalbuphine—Dermatitis—Docetaxel—pancreatic cancer	0.000717	0.00141	CcSEcCtD
Nalbuphine—Confusional state—Doxorubicin—pancreatic cancer	0.000716	0.00141	CcSEcCtD
Nalbuphine—Headache—Docetaxel—pancreatic cancer	0.000713	0.0014	CcSEcCtD
Nalbuphine—Oedema—Doxorubicin—pancreatic cancer	0.00071	0.0014	CcSEcCtD
Nalbuphine—Shock—Doxorubicin—pancreatic cancer	0.000699	0.00137	CcSEcCtD
Nalbuphine—Tachycardia—Doxorubicin—pancreatic cancer	0.000693	0.00136	CcSEcCtD
Nalbuphine—Paraesthesia—Epirubicin—pancreatic cancer	0.000689	0.00136	CcSEcCtD
Nalbuphine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000686	0.00135	CcSEcCtD
Nalbuphine—Dyspnoea—Epirubicin—pancreatic cancer	0.000684	0.00135	CcSEcCtD
Nalbuphine—Somnolence—Epirubicin—pancreatic cancer	0.000682	0.00134	CcSEcCtD
Nalbuphine—Nausea—Docetaxel—pancreatic cancer	0.000676	0.00133	CcSEcCtD
Nalbuphine—Dyspepsia—Epirubicin—pancreatic cancer	0.000675	0.00133	CcSEcCtD
Nalbuphine—Hypotension—Doxorubicin—pancreatic cancer	0.000663	0.00131	CcSEcCtD
Nalbuphine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000638	0.00125	CcSEcCtD
Nalbuphine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000633	0.00125	CcSEcCtD
Nalbuphine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000632	0.00124	CcSEcCtD
Nalbuphine—Somnolence—Doxorubicin—pancreatic cancer	0.000631	0.00124	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000627	0.00124	CcSEcCtD
Nalbuphine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000625	0.00123	CcSEcCtD
Nalbuphine—Urticaria—Epirubicin—pancreatic cancer	0.00061	0.0012	CcSEcCtD
Nalbuphine—Abdominal pain—Epirubicin—pancreatic cancer	0.000607	0.00119	CcSEcCtD
Nalbuphine—Body temperature increased—Epirubicin—pancreatic cancer	0.000607	0.00119	CcSEcCtD
Nalbuphine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000585	0.00115	CcSEcCtD
Nalbuphine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000581	0.00114	CcSEcCtD
Nalbuphine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000565	0.00111	CcSEcCtD
Nalbuphine—Urticaria—Doxorubicin—pancreatic cancer	0.000564	0.00111	CcSEcCtD
Nalbuphine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000561	0.0011	CcSEcCtD
Nalbuphine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000561	0.0011	CcSEcCtD
Nalbuphine—Asthenia—Epirubicin—pancreatic cancer	0.000551	0.00108	CcSEcCtD
Nalbuphine—Pruritus—Epirubicin—pancreatic cancer	0.000543	0.00107	CcSEcCtD
Nalbuphine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000523	0.00103	CcSEcCtD
Nalbuphine—Asthenia—Doxorubicin—pancreatic cancer	0.000509	0.001	CcSEcCtD
Nalbuphine—Dizziness—Epirubicin—pancreatic cancer	0.000507	0.000999	CcSEcCtD
Nalbuphine—Pruritus—Doxorubicin—pancreatic cancer	0.000502	0.000989	CcSEcCtD
Nalbuphine—Vomiting—Epirubicin—pancreatic cancer	0.000488	0.00096	CcSEcCtD
Nalbuphine—Rash—Epirubicin—pancreatic cancer	0.000484	0.000952	CcSEcCtD
Nalbuphine—Dermatitis—Epirubicin—pancreatic cancer	0.000483	0.000951	CcSEcCtD
Nalbuphine—Headache—Epirubicin—pancreatic cancer	0.000481	0.000946	CcSEcCtD
Nalbuphine—Dizziness—Doxorubicin—pancreatic cancer	0.00047	0.000924	CcSEcCtD
Nalbuphine—Nausea—Epirubicin—pancreatic cancer	0.000456	0.000897	CcSEcCtD
Nalbuphine—Vomiting—Doxorubicin—pancreatic cancer	0.000451	0.000889	CcSEcCtD
Nalbuphine—Rash—Doxorubicin—pancreatic cancer	0.000448	0.000881	CcSEcCtD
Nalbuphine—Dermatitis—Doxorubicin—pancreatic cancer	0.000447	0.00088	CcSEcCtD
Nalbuphine—Headache—Doxorubicin—pancreatic cancer	0.000445	0.000875	CcSEcCtD
Nalbuphine—Nausea—Doxorubicin—pancreatic cancer	0.000422	0.00083	CcSEcCtD
Nalbuphine—OPRK1—Signaling Pathways—SSTR2—pancreatic cancer	0.000395	0.000802	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000387	0.000787	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—GCG—pancreatic cancer	0.000387	0.000786	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000387	0.000786	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HEY2—pancreatic cancer	0.000383	0.000778	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCKBR—pancreatic cancer	0.000381	0.000775	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—SST—pancreatic cancer	0.00038	0.000773	CbGpPWpGaD
Nalbuphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.000379	0.000771	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GAST—pancreatic cancer	0.000374	0.00076	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—GCG—pancreatic cancer	0.000373	0.000759	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—SHH—pancreatic cancer	0.000371	0.000754	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000369	0.00075	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—IAPP—pancreatic cancer	0.000366	0.000744	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SSTR3—pancreatic cancer	0.000362	0.000735	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—DTX1—pancreatic cancer	0.000362	0.000735	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GLI1—pancreatic cancer	0.000358	0.000729	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—DTX4—pancreatic cancer	0.000358	0.000729	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000356	0.000724	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SCT—pancreatic cancer	0.000354	0.00072	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HEY1—pancreatic cancer	0.000354	0.00072	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—SST—pancreatic cancer	0.000354	0.00072	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000351	0.000714	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000351	0.000714	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CNR1—pancreatic cancer	0.000351	0.000714	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NRP1—pancreatic cancer	0.000349	0.000709	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000349	0.000709	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SSTR1—pancreatic cancer	0.000347	0.000705	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PPY—pancreatic cancer	0.00034	0.000691	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—GCG—pancreatic cancer	0.000339	0.000689	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCK—pancreatic cancer	0.000338	0.000687	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HEY2—pancreatic cancer	0.000336	0.000682	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SSTR2—pancreatic cancer	0.000334	0.000678	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CNR2—pancreatic cancer	0.00033	0.00067	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GLP1R—pancreatic cancer	0.00033	0.00067	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000329	0.000669	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GAST—pancreatic cancer	0.000328	0.000666	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000327	0.000664	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCKAR—pancreatic cancer	0.000324	0.000659	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000323	0.000657	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCKBR—pancreatic cancer	0.000322	0.000655	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—SST—pancreatic cancer	0.000321	0.000653	CbGpPWpGaD
Nalbuphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00032	0.000651	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—GCG—pancreatic cancer	0.000316	0.000641	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JAG2—pancreatic cancer	0.000314	0.000639	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SCT—pancreatic cancer	0.000311	0.000632	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HEY1—pancreatic cancer	0.000311	0.000632	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MEN1—pancreatic cancer	0.00031	0.00063	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GLI1—pancreatic cancer	0.000303	0.000616	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—DTX4—pancreatic cancer	0.000303	0.000616	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000301	0.000612	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CNR1—pancreatic cancer	0.000297	0.000603	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCK—pancreatic cancer	0.000296	0.000603	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SHH—pancreatic cancer	0.000296	0.000601	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NRP1—pancreatic cancer	0.000295	0.000599	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000295	0.000599	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000294	0.000597	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—IAPP—pancreatic cancer	0.000292	0.000593	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CNR2—pancreatic cancer	0.000289	0.000587	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GLP1R—pancreatic cancer	0.000289	0.000587	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000289	0.000587	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—GCG—pancreatic cancer	0.000287	0.000582	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCKAR—pancreatic cancer	0.000284	0.000578	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HEY2—pancreatic cancer	0.000284	0.000577	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTHLH—pancreatic cancer	0.00028	0.00057	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTCH1—pancreatic cancer	0.00028	0.00057	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GAST—pancreatic cancer	0.000277	0.000563	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JAG2—pancreatic cancer	0.000276	0.00056	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000273	0.000556	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MEN1—pancreatic cancer	0.000272	0.000552	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SCT—pancreatic cancer	0.000263	0.000534	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HEY1—pancreatic cancer	0.000263	0.000534	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SHH—pancreatic cancer	0.000259	0.000527	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000258	0.000524	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SST—pancreatic cancer	0.000256	0.000521	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—IAPP—pancreatic cancer	0.000256	0.00052	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000253	0.000514	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—JAG1—pancreatic cancer	0.000251	0.00051	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCK—pancreatic cancer	0.000251	0.000509	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOTCH3—pancreatic cancer	0.00025	0.000508	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTHLH—pancreatic cancer	0.000246	0.000499	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTCH1—pancreatic cancer	0.000246	0.000499	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CNR2—pancreatic cancer	0.000244	0.000496	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GLP1R—pancreatic cancer	0.000244	0.000496	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000244	0.000496	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCKAR—pancreatic cancer	0.00024	0.000488	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CNR1—pancreatic cancer	0.000236	0.000481	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JAG2—pancreatic cancer	0.000233	0.000474	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MEN1—pancreatic cancer	0.00023	0.000467	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.00023	0.000467	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—GCG—pancreatic cancer	0.000228	0.000464	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SST—pancreatic cancer	0.000225	0.000457	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000222	0.000452	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000222	0.00045	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—JAG1—pancreatic cancer	0.00022	0.000447	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SHH—pancreatic cancer	0.000219	0.000445	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000219	0.000445	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AGTR1—pancreatic cancer	0.000218	0.000443	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000218	0.000442	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—IAPP—pancreatic cancer	0.000216	0.00044	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STK11—pancreatic cancer	0.000215	0.000437	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTCH1—pancreatic cancer	0.000208	0.000422	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTHLH—pancreatic cancer	0.000208	0.000422	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CNR1—pancreatic cancer	0.000207	0.000422	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000202	0.00041	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000201	0.000409	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—GCG—pancreatic cancer	0.0002	0.000407	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000195	0.000396	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000194	0.000394	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AGTR1—pancreatic cancer	0.000191	0.000388	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SST—pancreatic cancer	0.00019	0.000386	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STK11—pancreatic cancer	0.000188	0.000383	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SMAD4—pancreatic cancer	0.000188	0.000382	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000187	0.000381	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000186	0.000378	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—JAG1—pancreatic cancer	0.000186	0.000378	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000185	0.000376	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HES1—pancreatic cancer	0.000184	0.000373	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.000177	0.00036	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000176	0.000357	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CNR1—pancreatic cancer	0.000175	0.000356	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CG—pancreatic cancer	0.00017	0.000346	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.00017	0.000345	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—GCG—pancreatic cancer	0.000169	0.000344	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000169	0.000344	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SMAD4—pancreatic cancer	0.000165	0.000335	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CD—pancreatic cancer	0.000165	0.000335	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000163	0.000332	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AGTR1—pancreatic cancer	0.000161	0.000328	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HES1—pancreatic cancer	0.000161	0.000327	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TERT—pancreatic cancer	0.000161	0.000327	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STK11—pancreatic cancer	0.000159	0.000324	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000154	0.000313	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HIF1A—pancreatic cancer	0.000154	0.000313	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TSC2—pancreatic cancer	0.000154	0.000312	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—APOE—pancreatic cancer	0.00015	0.000305	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CD—pancreatic cancer	0.00015	0.000304	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000148	0.000301	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KDR—pancreatic cancer	0.000147	0.000299	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000144	0.000292	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TERT—pancreatic cancer	0.000141	0.000287	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NFKBIA—pancreatic cancer	0.00014	0.000285	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SMAD4—pancreatic cancer	0.000139	0.000283	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000139	0.000282	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000138	0.00028	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HES1—pancreatic cancer	0.000136	0.000277	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000136	0.000276	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—NRAS—pancreatic cancer	0.000136	0.000276	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HIF1A—pancreatic cancer	0.000135	0.000274	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TSC2—pancreatic cancer	0.000135	0.000274	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGF—pancreatic cancer	0.000134	0.000272	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—APOE—pancreatic cancer	0.000132	0.000268	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CB—pancreatic cancer	0.00013	0.000265	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KDR—pancreatic cancer	0.000129	0.000262	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—CXCL8—pancreatic cancer	0.000125	0.000255	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—EGFR—pancreatic cancer	0.000124	0.000251	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000123	0.00025	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000122	0.000247	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TERT—pancreatic cancer	0.000119	0.000242	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000119	0.000242	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CG—pancreatic cancer	0.000119	0.000242	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—NRAS—pancreatic cancer	0.000119	0.000242	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000118	0.00024	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGF—pancreatic cancer	0.000118	0.000239	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—KRAS—pancreatic cancer	0.000117	0.000237	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HIF1A—pancreatic cancer	0.000114	0.000232	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TSC2—pancreatic cancer	0.000114	0.000231	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—APOE—pancreatic cancer	0.000111	0.000226	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KDR—pancreatic cancer	0.000109	0.000222	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—EGFR—pancreatic cancer	0.000108	0.00022	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000107	0.000218	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CD—pancreatic cancer	0.000105	0.000212	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CB—pancreatic cancer	0.000104	0.000211	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NFKBIA—pancreatic cancer	0.000104	0.000211	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000104	0.00021	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NOTCH1—pancreatic cancer	0.000103	0.000209	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—KRAS—pancreatic cancer	0.000102	0.000208	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CG—pancreatic cancer	0.0001	0.000204	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—NRAS—pancreatic cancer	0.0001	0.000204	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CXCL8—pancreatic cancer	9.98e-05	0.000203	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGF—pancreatic cancer	9.93e-05	0.000202	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—HRAS—pancreatic cancer	9.92e-05	0.000202	CbGpPWpGaD
Nalbuphine—OPRD1—GPCR downstream signaling—AKT1—pancreatic cancer	9.64e-05	0.000196	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CASP3—pancreatic cancer	9.56e-05	0.000194	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—PIK3CA—pancreatic cancer	9.4e-05	0.000191	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CCND1—pancreatic cancer	9.3e-05	0.000189	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—CTNNB1—pancreatic cancer	9.21e-05	0.000187	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—EGFR—pancreatic cancer	9.15e-05	0.000186	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CB—pancreatic cancer	9.11e-05	0.000185	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MMP9—pancreatic cancer	9.03e-05	0.000184	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PTEN—pancreatic cancer	8.98e-05	0.000182	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CD—pancreatic cancer	8.83e-05	0.00018	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling by GPCR—AKT1—pancreatic cancer	8.76e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CXCL8—pancreatic cancer	8.75e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.75e-05	0.000178	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—HRAS—pancreatic cancer	8.7e-05	0.000177	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—KRAS—pancreatic cancer	8.65e-05	0.000176	CbGpPWpGaD
Nalbuphine—OPRK1—GPCR downstream signaling—AKT1—pancreatic cancer	8.46e-05	0.000172	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CASP3—pancreatic cancer	8.38e-05	0.00017	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—SRC—pancreatic cancer	8.33e-05	0.000169	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CCND1—pancreatic cancer	8.16e-05	0.000166	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—VEGFA—pancreatic cancer	8.11e-05	0.000165	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—CTNNB1—pancreatic cancer	8.08e-05	0.000164	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—STAT3—pancreatic cancer	8.03e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—NRAS—pancreatic cancer	8.01e-05	0.000163	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—PIK3CA—pancreatic cancer	7.95e-05	0.000162	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MMP9—pancreatic cancer	7.92e-05	0.000161	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PTEN—pancreatic cancer	7.87e-05	0.00016	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CB—pancreatic cancer	7.7e-05	0.000157	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling by GPCR—AKT1—pancreatic cancer	7.68e-05	0.000156	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—MYC—pancreatic cancer	7.46e-05	0.000152	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TGFB1—pancreatic cancer	7.44e-05	0.000151	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CXCL8—pancreatic cancer	7.4e-05	0.00015	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—HRAS—pancreatic cancer	7.35e-05	0.000149	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—SRC—pancreatic cancer	7.3e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—EGFR—pancreatic cancer	7.3e-05	0.000148	CbGpPWpGaD
Nalbuphine—OPRM1—GPCR downstream signaling—AKT1—pancreatic cancer	7.15e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—VEGFA—pancreatic cancer	7.11e-05	0.000145	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CASP3—pancreatic cancer	7.08e-05	0.000144	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—STAT3—pancreatic cancer	7.04e-05	0.000143	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—NRAS—pancreatic cancer	7.02e-05	0.000143	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—KRAS—pancreatic cancer	6.89e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CCND1—pancreatic cancer	6.89e-05	0.00014	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—CTNNB1—pancreatic cancer	6.83e-05	0.000139	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MMP9—pancreatic cancer	6.69e-05	0.000136	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PTEN—pancreatic cancer	6.65e-05	0.000135	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—MYC—pancreatic cancer	6.54e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TGFB1—pancreatic cancer	6.53e-05	0.000133	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling by GPCR—AKT1—pancreatic cancer	6.49e-05	0.000132	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—EGFR—pancreatic cancer	6.4e-05	0.00013	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—PIK3CA—pancreatic cancer	6.33e-05	0.000129	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—SRC—pancreatic cancer	6.17e-05	0.000125	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—TP53—pancreatic cancer	6.13e-05	0.000125	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—KRAS—pancreatic cancer	6.04e-05	0.000123	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—VEGFA—pancreatic cancer	6.01e-05	0.000122	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—STAT3—pancreatic cancer	5.95e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—NRAS—pancreatic cancer	5.94e-05	0.000121	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—HRAS—pancreatic cancer	5.86e-05	0.000119	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—PIK3CA—pancreatic cancer	5.55e-05	0.000113	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—MYC—pancreatic cancer	5.53e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TGFB1—pancreatic cancer	5.52e-05	0.000112	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—EGFR—pancreatic cancer	5.41e-05	0.00011	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—TP53—pancreatic cancer	5.37e-05	0.000109	CbGpPWpGaD
Nalbuphine—OPRD1—Signaling Pathways—AKT1—pancreatic cancer	5.17e-05	0.000105	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—HRAS—pancreatic cancer	5.14e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—KRAS—pancreatic cancer	5.11e-05	0.000104	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—PIK3CA—pancreatic cancer	4.69e-05	9.54e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—TP53—pancreatic cancer	4.54e-05	9.23e-05	CbGpPWpGaD
Nalbuphine—OPRK1—Signaling Pathways—AKT1—pancreatic cancer	4.54e-05	9.22e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—HRAS—pancreatic cancer	4.34e-05	8.83e-05	CbGpPWpGaD
Nalbuphine—OPRM1—Signaling Pathways—AKT1—pancreatic cancer	3.83e-05	7.79e-05	CbGpPWpGaD
